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a b s t r a c t
Goniothalamin (GTN) isolated from Goniothalamus sp. has been demonstrated to induce apoptosis in a
variety of cancer cell lines including Jurkat T leukemia cells. However, the mechanism of GTN-induced
apoptosis upstream of mitochondria is still poorly deﬁned. In this study, GTN caused a decrease in GSH
with an elevation of reactive oxygen species as early as 30min and DNA damage as assessed by Comet
assay. Analysis using topoisomerase II processing of supercoiled pBR 322 DNA showed that GTN caused
DNA damage via a topoisomerase II-independent pathway suggesting that cellular oxidative stress may
contribute to genotoxicity. A 12-fold increase of caspase-2 activity was observed in GTN-treated Jurkat
cells after 4h treatment and this was conﬁrmed using Western blotting. Although the caspase-2 inhibitor
Z-VDVAD-FMK inhibited the proteolytic activity of caspase-2, apoptosis ensued conﬁrming that caspase-xidative stress
aspase-2
cl-2
2 activity was not crucial for GTN-induced apoptosis. However, GTN-induced apoptosis was completely
abrogated by N-acetylcysteine further conﬁrming the role of oxidative stress. Since cytochrome c release
was observed as early as 1h without any appreciable change in Bcl-2 protein expression, we further
investigated whether overexpression of Bcl-2 confers resistance in GTN-induced cytotoxicity. Using a
panel of Jurkat Bcl-2 transfectants, GTN cytotoxicity was not abrogated in these cells. In conclusion, GTN
oxidinduces DNA damage and
and Bcl-2.
. Introduction
Styryl-lactones are secondary metabolites isolated from Gonio-
halamus plant species. Currently, there are approximately 100
tyryl-lactones either discovered from natural products or syn-
hetic analogs. These compounds have been demonstrated to be
ytotoxic with prefential killing of cancer cells (de Fátima et al.,
006). Goniothalamin (GTN) a plant styryl-lactone isolated from
oniothalamus andersonii, induces cytotoxicity in a variety of can-
er cell lines including cervical (Hela), gastric (HGC-27), ovarian
Caov-3), kidney (786-0), breast carcinomas (MCF7, T47D and
DA-MB-231) and leukemia (HL-60, Jurkat and CEM-SS) (Ali et al.,
∗ Corresponding author at: Faculty of Allied Health Sciences, Universiti
ebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.
el.: +60 3 92897602; fax: +60 3 26938717.
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378-4274 © 2009 Elsevier Ireland Ltd. 
oi:10.1016/j.toxlet.2009.12.010
Open access under CC BY license. ative stress resulting in apoptosis which is independent of both caspase-2
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1997; Inayat-Hussain et al., 1999, 2003; Rajab et al., 2005; Pihie
et al., 1998; Alvin Lee and Azimahtol Hawariah, 2003; Teoh and
Azimahtol Hawariah, 2000; de Fátima et al., 2006). The mechanism
ofGTN-induced cytotoxicity in human leukemia (HL-60 and Jurkat)
and human breast cancer cells (MDA-MB-231) has been conﬁrmed
to occur via apoptosis (Chen et al., 2005; Inayat-Hussain et al., 1999,
2003).
It has been reported that cytotoxic stress either from DNA
damage or mitochondrial impairment leads to apoptosis via the
intrinsic pathway (Chan et al., 2006; Kang and Reynolds, 2009).
The intrinsic pathway involves the release of proapoptotic proteins
including cytochrome c from the inner membrane of mitochondria
to the cytosol leading to activationof caspase-9 (Riedl and Salvesen,
2007). Numerous studies have demonstrated that the oncoprotein
Open access under CC BY license. Bcl-2 can inhibit apoptosis by inhibiting the release of cytochrome
c and can also modulate oxidant induced apoptosis (Schwartz and
Hockenbery, 2006). Since the discovery of the caspase-9 apopto-
some complex (Zou et al., 1999), more recent studies have shown
that the initiator caspase-2 also forms a complex with RAIDD, a
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eath receptor molecule and the p53 inducible death domain PIDD
orming a PIDDosome complex (Tinel and Tschopp, 2004). Impor-
antly, caspase-2 has been demonstrated in a variety of cell lines
o be activated upstream of mitochondria in genotoxin-induced
poptosis. Cleavageof theproapoptotic Bcl-2 familymemberBidby
aspase-2 has been shown to be required for cytochrome c release
uggesting a potentially crucial role for caspase-2.
Since goniothalamin has recently been demonstrated to induce
NA damage in vascular smooth muscle cells, HL-60 and CEM-
S leukemia cells (Rajab et al., 2005), the role of caspase-2 in
oniothalamin-induced apoptosis was investigated in this study.
urthermore, the anti-apoptotic effects of Bcl-2were further deter-
ined using a panel of Bcl-2-transfected Jurkat cells expressing
arying level of Bcl-2 proteins (Johnson et al., 1999). Our results
emonstrate that goniothalamin-induced DNA damage and ROS
eads to apoptosis through caspase-2- andBcl-2-independentpath-
ays.
. Materials and methods
.1. Chemicals
Goniothalamin was obtained fromGoniothalamus andersonii as described previ-
usly (Inayat-Hussain et al., 1999). All other chemicals were purchased from Sigma
nless stated otherwise.
.2. Cell culture
Jurkat T lymphoblastic leukemia cells (clone E6-1) were purchased from ATCC
nd maintained in RPMI-1640 medium (GIBCO) supplemented with 10% heat inac-
ivated fetal calf serum (PAA), 2mM l-glutamine and 1% pen/strep (PAA), at 37 ◦C in
5% CO2 humidiﬁed incubator. All experiments were carried out using cells in loga-
ithmic growth phase. Bcl-2 transfected cells were obtained as described previously
Johnson et al., 1999) and were maintained in Hygromycin B (Merck) supplemented
edium to maintain the overexpression of Bcl-2.
.3. Determination of GSH
GSH was quantiﬁed as described previously by Ellman (1959) with modiﬁca-
ions. Brieﬂy, 50M GTN-treated cells (1×106 cells) were collected and washed
ith chilled PBS. The cells were pelleted at 220× g for 5min. Subsequently, the
upernatant was discarded and pellet was mixed with 100l of ice cold lysis buffer
50mMK2HPO4, 1mMEDTA, pH 6.5 and 0.1%v/v Triton X-100). The cellswere incu-
atedon ice for 15minwith gentle tapping fromtime to time. The crude lysateswere
leared by centrifugation at 10,000× g for 15min at 4 ◦C. At this point, the lysates
ere used immediately or stored at −80 ◦C for up to 2 days. Then, 50l of lysates
nd GSH standards (twofold dilution from 1.25mM to 0mM dissolved in reaction
uffer [0.1MNa2HPO4·7H2Oand1mMEDTA,pH6.5])werepipetted intodesignated
ells in 96-well plate. After adding 40l of reaction buffer (0.1M Na2HPO4·7H2O
nd 1mM EDTA, pH 8), 10l of 4mg/ml DTNB in reaction buffer pH 8 was added
o wells containing samples and standards. The plate was incubated for a further
5min at 37 ◦C. Absorbance of each well was measured at 405nm using microplate
eader. The concentration of free thiols in the samples was calculated based on GSH
tandard and expressed as nmol/mg protein.
.4. Flow cytometry assessment of reactive oxygen species
The reactive oxygen species (ROS) level was assessed as described previously
y Li et al. (2002) with slight modiﬁcation. Brieﬂy, GTN-treated cells (1×106 cells)
ere collected via centrifugation. The supernatant was discarded and the cells
ere resuspended with 1ml pre-warmed FBS-free fresh medium and 1l of 10mM
ydroethidine (HE) (Molecular Probes) solutionwas added. The cell suspension con-
aining 10M HE was incubated in the dark at 37 ◦C for 30min. Subsequently, the
ells were centrifuged at 220× g for 5min and were washed with 1ml chilled PBS.
he supernatant was discarded and 500l of cold PBS was mixed with the pel-
ets. The stained cell suspension was transferred to ﬂow tubes and analyzed with
ACSCalibur Flow Cytometer (BD Bioscience) using FL2 channel on 10,000 cells.
.5. Alkaline comet assay
The comet assay was carried out as described previously (Chan et al., 2006).
rieﬂy, 500l GTN-treated cells (1×106 cells/ml) were transferred to a tube for
entrifugation (2500 rpm/5min at 4 ◦C). The supernatant was removed and pellet
as washed with Ca2+- and Mg2+-free PBS and re-centrifuged. The cell pellets were
ixed thoroughly with 80l of 0.6% low melting agar. The mixture was then pipet-
ed onto the hardened 0.6% normal melting agar as the ﬁrst layer gel on the slide.
over slips were placed to spread the mixture and slides were left on ice for lowy Letters 193 (2010) 108–114 109
melting agar to solidify. Following the removal of the cover slips, the embedded
cells were lysed in a buffer containing 2.5M NaCl, 100mM EDTA, 10mM Tris and
1% Triton X-100 for 1h at 4 ◦C. Slides were soaked in electrophoresis buffer solution
for 20min for DNA unwinding before electrophoresis at 300mA, 25V for 20min.
Subsequently, the slides were rinsed with neutralising buffer for 5min and stained
with 50l of 10g/ml ethidium bromide solution. Slides were left overnight at 4 ◦C
before analysis, using a ﬂuorescent microscope equipped with 590nm ﬁlter. The
DNA damage was assessed on 50 cells where tail moment (tail length multiplied by
the fraction of DNA in the tail) was quantiﬁed using the Comet Assay III (Perceptive
Instrument Ltd.).
2.6. Immunoblotting
GTN-treated cells (2×106 cells/ml) were prepared for SDS–PAGE as previously
described (Inayat-Hussain et al., 1999). Cellular proteins were resolved on 12%
(caspases-2, -3 and Bcl-2) or 15% (cytochrome c) SDS–polyacrylamide gels under
denaturing conditions and blotted onto a PVDF membrane (Amersham). Mouse
monoclonal anti-caspase-2, rabbit polyclonal anti-caspase-3 and rabbit monoclonal
anti-Bcl-2 antibody were purchased from Cell Signaling Technology Inc. For detec-
tion of cytochrome c, the cell pellet was resuspended in cytosol extraction buffer,
and cytosolic extracts were prepared as described previously (Herrera et al., 2001).
Mouse monoclonal anti-cytochrome c antibody was purchased from BD Pharmin-
gen. Actin was detected for loading control using mouse monoclonal anti-actin
antibody. Proteins were detected by Enhanced Chemi-Luminescence staining.
2.7. Assessment of apoptosis
GTN-induced Jurkat cells apoptosis was assessed based on the externalization
of phosphatidylserine. Cells treated with GTN (1×106 cells) were collected and
washed once with PBS. In some experiments, the cells were pre-treated with 50M
Z-VAD-FMK, Z-VDVAD-FMK or 10mM N-acetylcysteine (NAC) for 1h. The pellet
was suspended with 100l annexin binding buffer (10mM Hepes/NaOH pH 7.4,
150mM NaCl, 5mM KCl, 1mM MgCl2·6H2O and 1.8mM CaCl2·2H2O) and the cells
weremixedwith 1.5l annexin V-FITC (Invitrogen). Following 15min incubation in
dark, 10l propodium iodide (50g/ml) was added to cells and which were incu-
bated for a further 2min. Annexin binding buffer (400l) was added to the cells
suspension and analyzed with FACSCalibur Flow Cytometer (BD Bioscience).
2.8. Determination of caspase-2 proteolytic activity
The caspase-2 proteolytic activity was detected using BioVision Caspase-2 Flu-
orometric kit based on speciﬁc ﬂuorogenic substrates. Brieﬂy, 50M GTN-treated
cells (2×106 cells) with and without 1h pretreatment with 50M Z-VDVAD-FMK
(Calbiochem) were collected by centrifugation at 200× g for 5min. Cells were
washed with chilled PBS. After centrifugation, supernatant was discarded and pellet
was resuspended with 100l of cell lysis buffer (BioVision). Following incubation
for 10min on ice, the cell lysates were centrifugated for 1min at 10,000× g and the
resulting supernatant was transferred to fresh tubes on ice. The reaction was pre-
pared in opaque-walled 96-well plates. 50g protein sample in a volume of 50l
was added to thewell. 50l of 2× reaction buffer (BioVision) containing 10mMDTT
was then added to each sample. Subsequently, VDVAD-AMC was added to the sam-
ples and incubated at 37 ◦C for 2h. The sample ﬂuorescence was measured using a
ﬂuorescenceplate reader anddatawas expressed aspercentageof caspase-2 activity
over control.
2.9. Determination of caspase-3 proteolytic activity
Cells were treated in an opaque-walled 96-well plate at a density of 1×106 cells
per well in a volume of 200l and kept under 5% CO2 at 37 ◦C for 4h. Caspase-
Glo® Buffer (Promega) was thawed and equilibrated to room temperature and the
solutionwas used to dissolve lyophilized Caspase-Glo® Substrate. Then, themixture
wasvortexed toobtainahomogenoussolution. The96-wellplatewasequilibrated to
room temperature for 30min before the end of treatment. 100l of cell suspension
was discarded from each well before 100l of Caspase-Glo® Reagent was added to
cells. The plate was placed on an orbital shaker for 30 s and then further incubated
at room temperature for 2h. The luminescence signal was then measured using
a luminometer and data was expressed as percentage of caspase-3 activity over
control.
2.10. MTT assay
Cytotoxicity of GTN was evaluated using the MTT assay. Brieﬂy, cells were
treated at 1×106 cells/ml with ﬁnal concentrations of 12.5M, 25M, 50M and
100M GTN. After 24h incubation, 20l of 5mg/ml MTT solution was added to
each well and further incubated for 4h at 37 ◦C. Subsequently, 150l medium was
discarded from each well before adding 150l DMSO (Fischer Scientiﬁc). For com-
plete dissolution, the plate was incubated for 15min with gentle shaking for 5min.
The cytotoxic effects of GTN were monitored by measuring the absorbance of each
well at 570nm. Mean absorbance for each GTN concentration was expressed as
a percentage of absorbance in the vehicle control wells. IC50 represents the GTN
110 S.H. Inayat-Hussain et al. / Toxicology Letters 193 (2010) 108–114
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cig. 1. GTN induces oxidative stress in Jurkat cells. The early decrease of GSH was as
he formation of superoxide was evaluated using hydroethidine in conjunction wi
xperiments. *p<0.05 against control.
oncentration that reduced the mean absorbance at 570nm to 50% of those in the
ehicle control wells.
.11. Topoisomerase II˛-mediated DNA cleavage
Effects of GTN on stabilization of topoisomerase II-DNA complexes were evalu-
ted using the method of Gantchev and Hunting (1997). Reactions were performed
n a buffer containing 10mM Tris–HCl, pH 7.7, 50mM KCl, 0.1mM EDTA, 5mM
gCl2.2H2O, 5mg BSA and 0.5mM ATP. Topoisomerase II enzyme, GTN, and etopo-
ide as a positive control, at the indicated concentrations were incubated in the
uffer on ice for 10min. Reactions were initiated by the addition of pBR322 plasmid
NA and transferred to a 37 ◦C water bath. Reactions contained 6units (∼13nM)
f human topoisomerase II (TopoGen) and 300ng of pBR322 DNA (New England
iolabs) per 20l sample volume. Following 10min incubation, the enzyme activ-
ty was terminated and cleavage products were trapped by the addition of 2l of
0% SDS followed by the addition of EDTA and NaCl to 10mM and 20mM, respec-
ively. Reactions were incubated for an additional 5min at 37 ◦C. Enzyme trapped in
leavable complexes was removed by proteolysis with proteinase K at a ﬁnal con-
entration of 0.8mg/ml and incubated at 55 ◦C for 2h to reveal any linearized DNAin 50M GTN-treated cells at 30min and 1h using the Ellman reagent (A) whereas
w cytometry (B). Data represent the mean± SEM from at least three independent
products. Samples were then electrophoresed at 2V/cm for 18h on 1.3% agarose
gels in Tris–acetate–EDTA buffer containing 0.7g/ml of ethidium bromide. Using
this system, different forms of migrated DNA were as follows: relaxed (greatest
mobility), supercoiled, linear and nicked open circular (lower mobility).
2.12. Statistical analysis
The data are expressed as the mean± standard error of mean (SEM) from at
least three independent experiments. Statistical signiﬁcance was evaluated using
the Student’s t-test for comparisons between two mean values whereas one-way
ANOVA with Tukey post hoc test was used to test the signiﬁcance between multiple
groups. Differences were considered signiﬁcant with a probability level of p<0.05.
3. Results3.1. Role of oxidative stress in GTN-induced apoptosis
It has been shownpreviously that GTN induces redox changes in
MDA-MB-231 (Chen et al., 2005). In this study, Jurkat cells treated
S.H. Inayat-Hussain et al. / Toxicology Letters 193 (2010) 108–114 111
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Fig. 3, the effects of different concentrations of GTN on topo II
processing of supercoiled pBR 322 DNA were determined. Increas-
ing concentrations of GTN had no effect on the ability of topo II
to relax supercoiled DNA. Etoposide, a well-known topoisomeraseig. 2. DNA damage in GTN-treated Jurkat cells. Cells were treated with 50M GT
ection 2. A pictorial image of intact and damaged DNA in Jurkat cells is presented
ean± SEM from at least three independent experiments. *p<0.05 against control
ith 50M of GTN resulted in a signiﬁcant loss of GSH as early as
0min (Fig. 1A). This result suggests the generation of oxidative
tress in these cells and further studies were carried out to monitor
he production of reactive oxygen species (ROS) using the ﬂuores-
ent probe hydroethidine (HE) in conjunctionwith ﬂow cytometry.
ur study demonstrated the ability of Jurkat cells to produce ROS
hen the positive control menadione was used (Fig. 1B). When
urkat cells were treated with GTN, an increase of ethidine produc-
ion, the oxidised product of HE was observed as early as 30min
onsistent with the early loss of GSH (Fig. 1B). ROS production
emained elevated for the ﬁrst 2h. To verify the role of ROS in GTN
reatment, Jurkat cells were pre-treated with NAC, an antioxidant,
nd cell death was assessed as shown in Fig. 1C. Cell death induced
y GTN was inhibited by NAC, further conﬁrming the role of ROS in
ytotoxic effects of GTN.
.2. Early DNA damage occurs in GTN-treated Jurkat cells
The importance of radical induced DNA damage is becoming
ore apparent especially with superoxide anions, hydrogen per-
xide and hydroxyl radicals (reviewed in Genestra, 2007). Here,
ssessment of DNA damage was carried out using alkaline Comet
ssay. Control untreated cells show a round and healthy looking
ucleus where the DNA is contained in the nucleus (Fig. 2A). In the
resence of DNA damage, there will be fragments of DNA migrat-
ng out of the nucleus forming a comet-like tail. Consistent with
he loss of GSH and production of ROS, GTN-treated Jurkat cells
lso resulted in DNA damage as measured by tail moment (Fig. 2B)30min and DNA damage was assessed using alkaline comet assay as described in
el A. The DNA damage data were expressed as tail moment (B). Data represent the
as early as 30min, which can be seen before any morphological
changes associated with late apoptosis such as nuclear condensa-
tion.
In order to gain further insight into the possible nuclear target
of GTN,we investigated its effects on the activity of human topoiso-
merase II (topo II) since another styryl-lactone, namely Howiinol
A, is a topoisomerase II poison (Xu and He, 1999). As shown inFig. 3. GTN induces DNA damage independent of topoisomerase II inhibition. The
effect of GTN on topoisomerase II inhibition was assessed using pBR322 DNA as
described in Section 2.
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Fig. 4. GTN-induced Jurkat cells involves caspases. Apoptosis induced by 50M
GTN was assessed based on the externalization of phosphatidylserine (A). In some
experiments the cells were pre-treated for 1h with 50M Z-VAD-FMK or 50M12 S.H. Inayat-Hussain et al. / Tox
nhibitor (Hande, 2006) alone stabilized the enzyme-linked DNA
omplexes (indicated by the linear band). However, co-incubation
ith increasing GTN concentrations had no effect on etoposide lin-
ar band formation.
.3. Caspase-2 is signiﬁcantly increased but not crucial for
TN-induced apoptosis
It has been reported that genotoxic stress causes activation of
aspase-2 upstream of mitochondria and that this caspase is the
pical caspase which is required for apoptosis (Zhivotovsky and
rrenius, 2005). To determine the functional importance of api-
al caspase-2 during apoptosis, Jurkat cells were pre-treated with
0M Z-VDVAD-FMK for 30min and apoptosis was assessed by
ow cytometry using annexin V and propidium iodide. Treatment
ith 50M GTN resulted in 36.9±2.0% apoptosis in Jurkat cells
s shown in Fig. 4A. The speciﬁc inhibitor of caspase-2 did not
lock apoptosis induced by GTN even though caspase-2 prote-
lytic activity was completely abrogated in the presence of this
nhibitor. In agreement with our previous study (Inayat-Hussain
t al., 1999), the pan-caspase inhibitor z-VAD-FMK abolished GTN-
nduced apoptosis.
To further investigate if caspase-2was activated inGTN-induced
poptosis, the speciﬁc caspase-2 ﬂuorogenic substrate VDVAD-
FC cleavage activity was analysed. Cleavage of this ﬂuorogenic
ubstrate increased signiﬁcantly to 12-fold over control in Jurkat
ells after 4h of treatment with GTN (Fig. 4B). Pre-treatment
ith 50M Z-VDVAD-FMK blocked caspase-2 proteolytic activ-
ty in GTN-treated Jurkat cells. To verify that caspase-2 processing
ccurred in GTN-treated Jurkat cells, Western blotting was carried
ut and using a speciﬁc antibody to caspase-2, we found that cleav-
ge of this caspase to its active subunit (33kDa) occurred as early
s 3h. The downstream executioner caspase-3 was concomitantly
rocessed as shown in Fig. 4C. Intact caspase-3 was cleaved to its
ctive subunit as early as 3h and by 4h all the intact protein was
leaved to its active subunit (17kDa).Usinga luminogenic substrate
or caspase-3, an 8-fold increase of the activity of this caspase over
ontrols was observed (Fig. 4D).
.4. Bcl-2 is not crucial in GTN-induced cytotoxicity
During apoptosis, opening of the permeability transition pore
auses the release of proapoptotic proteins including cytochrome
which is tightly controlled by Bcl-2 family proteins (Gogvadze
t al., 2008). As shown in Fig. 5, GTN treatment caused a release
f cytochrome c as early as 1h, however the protein level of Bcl-
remained the same throughout the ﬁrst 3h of GTN treatment.
lthough there was a reduction in the level of Bcl-2 protein at 4h,
ur data suggests that the reduction in Bcl-2 is not important for
ell death induced by GTN.
To conﬁrm that the anti-apoptotic Bcl-2 protein does not reg-
late cell death induced by GTN, a panel of Bcl-2 overexpressing
urkat cells was employed in this study. The MTT cytotoxicity assay
as employed and the inhibition concentrations (IC50) of GTN on
he Bcl-2 stably transfected Jurkat cells were determined as shown
n Table 1. Four clones of stably transfected Jurkat cells were used
s described previously (Johnson et al., 1999). These clones namely
-Bcl2/C4.1, J-Bcl2/C5.2, J-Bcl/C6.1, and J-Bcl2/A8 harbor the full-
ength human Bcl-2 cDNA and express between a 3-7 fold increase
n theBcl-2protein. The IC50 for pEBS7vector control cells after 24h
reatment with GTN was 35M. Our study shows that the IC50s for
TN in the Bcl-2 stable transfectants ranged from 26M to 33M
nd were not signiﬁcantly different from the control values, con-
rming that the oncoprotein Bcl-2 did not confer resistance to GTN
ytotoxicity. We have previously shown that these panels of Bcl-2
ransfectants are resistant to Fas and staurosporine (Johnson et al.,
Z-VDVAD-FMK before treatment with GTN for 4h. The caspase-2 activity in GTN-
treated cells was determined using speciﬁc substrate VDVAD-AMC (B). Processing
of pro-caspase-2 and pro-caspase-3 in 50MGTN-treated cellswere detected using
immunoblotting (C). The caspase-3 activity was conﬁrmed using speciﬁc caspase-
3 substrate DEVD-aminoluciferin (D). Values were mean± SEM from at least three
independent experiments. *p<0.05 against control.
S.H. Inayat-Hussain et al. / Toxicolog
Fig. 5. Effects of GTN on Bcl-2 expression and cytochrome c release in Jurkat cells.
Cells were treated with various exposure times and the expression of Bcl-2 and
cytosolic cytochrome c was detected using immunoblotting.
Table 1
Effects of GTN on a panel of Bcl-2 overexpressed
Jurkat cells. Protein expression of Bcl-2 in the
Jurkat clones was A8>C5.2 >C4.1 >C6.1 with
pEBS7 as vector control. Cytotoxicity of GTN on
these cells was evaluated using MTT assay.
Clone IC50
pEBS7 38.3 ± 6.5
C6.1 33.5 ± 13.6
C4.1 28.0 ± 8.2
C5.2 32.5 ± 2.5
A8 30.9 ± 5.2
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We have employed Bcl-2-overexpressing Jurkat cells to demon-ig. 6. Sensitivity of Jurkat Bcl-2 stable transfectants (clonesC5.2 andC6.1) to etopo-
ide. Cytotoxicity of etoposide was assessed by MTT on vector control (pEBS7), C6.1
nd C5.2 cells and the IC50s were 3M, 8M and 13M respectively.
999). Using 2 clones namely C5.2 and C6.1, we again conﬁrmed
hat these BCL-2 tranfectants were resistant to another positive
ontrol, etoposide, as shown in Fig. 6.
. Discussion
Styryl-lactones have gained a considerable interest in the
nticancer drug development area. Currently approximately 100
ompounds have been isolated and/or synthesised (de Fátima et
l., 2006). In this study, the mechanism of apoptosis induced by
oniothalamin was investigated. Our data show that there was a
eduction of GSH as early as 30min in GTN-treated Jurkat cells. This
s consistent with a recent study where GTN-treated MDA-MB-431
ells reduced the total contents of intracellular GSH and protein
hiol as assessed by monobromobimane (Chen et al., 2005). This
eduction of GSH could be attributed to the production of reactive
xygen species or direct alkylation of GTN to thiol groups on pro-
eins including GSH. Using hydroethidine in conjunction with ﬂow
ytometry, our results conﬁrmed the production of ROS as earlyy Letters 193 (2010) 108–114 113
as 30min (Fig. 1B). The role of ROS in GTN toxicity was conﬁrmed
using NAC in Jurkat cells (Fig. 1C) and this is in agreement with
previous studies where GTN-induced apoptosis occurs via ROS in
MDA-MB-231 cells, an event that is also blocked by NAC (Chen et
al., 2005). This reactive oxygen species may contribute to the loss
of GSH and also to DNA strand breaks, which we have shown to be
independent of topoisomerase II inhibition (Fig. 3).
The DNA damage seen in GTN-treated Jurkat cells subsequently
leads to apoptosis induction. Although there is no direct evidence
to corroborate that DNA damage is responsible for apoptosis, our
recent studies demonstrated that using mouse W7.2 T cells over-
expressed with full-length receptor for activated protein kinase-1
(RACK-1), early DNA damage induced by GTN was inhibited and
there was no further cytotoxicity observed (Inayat-Hussain et al.,
2009). In addition to the absence of Bax, Jurkat cells also lack p53
protein expression (Karpinich et al., 2006). Therefore, the DNA
damage induced by GTN resulted in p53-independent apoptosis.
However, the p73 gene may replace p53 as an apoptosis signal in
these Jurkat cells. Considering that p73 has p53-like properties, it
is likely to be involved in DNA damage induced apoptosis in GTN-
treated Jurkat cells. Several lines of evidence suggest that p73 is
able to induce apoptosis in p53-independent manner. For example,
overexpression of p73 or DNA damage-mediated p73 upregulation
induces apoptosis in p53 null cells (Ozaki and Nakagawara, 2005).
In Jurkat cells, DNA damaging agents, such as etoposide, have been
demonstrated to trigger the upregulation of p73 as an apoptotic
signal followed by mitochondrial translocation of truncated Bid
and release of cytochrome c into cytosol (Karpinich et al., 2006).
Due to its structural similarities to p53 protein, p73 can bind to
p53-responsive elements and transactivate an overlapping set of
p53-target genes such as PIDD (Ozaki and Nakagawara, 2005). The
upregulated PIDD binds to RAIDD and caspase-2 forming a com-
plex called the PIDDosome, which resulted in the processing of
caspase-2, as seen in our apoptotic model.
The increase in caspase-2 activity is not crucial in GTN-induced
apoptosis as a speciﬁc caspase-2 inhibitor did not abrogate the
externalization of phosphatidylserine. It should be noted that
caspase inhibitor blocks activity of the caspase and not the pro-
cessing of its zymogen to its active form. This is important since
Robertson et al. (2004) have demonstrated that processed caspase-
2 can induce the release of cytochrome c independently of the
protease activity. Furthermore, the release of cytochrome c pre-
cedes caspase-2 activation in GTN-induced Jurkat apoptosis as
shown in Fig. 5 which is in contrast with previous ﬁndings. It has
been reported that caspase-2 is activated early in the apoptotic
process and induces the release of cytochrome c upon mitochon-
drial translocation (Zhivotovsky and Orrenius, 2005). Therefore,
the release of cytochrome c in this study may well be initiated
by the upregulation of p73 tumor suppressor protein (Melino et
al., 2004). In addition, the release of cytochrome c in GTN-treated
Jurkat can also be a direct effect of an early increase in superoxide
level. The oxidation of critical thiol residues of VDAC and ANT has
been demonstrated to cause permeabilization of the mitochondria
membrane (Costantini et al., 2000; Madesh and Hajnóczky, 2001).
Oxidation of mitochondrial cardiolipin releases bound cytochrome
c into the mitochondrial intermembrane space. These apoptogenic
proteins will then be release into the cytosol via exit conduit
formed by oxidised VDAC and ANT pores. Once in the cytosol,
the cytochrome c forms the apoptosome complex which activates
caspase-9 in Jurkat as reported previously (Inayat-Hussain et al.,
2003).strate the regulation of Bcl-2 in the release of cytochrome c.
Intriguingly, the overexpressed Bcl-2 did not protect the cells from
the cytotoxic effects of GTN as assessed by MTT assay. This was
in agreement with previous studies where Bcl-2 did not confer
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Zhivotovsky, B., Orrenius, S., 2005. Caspase-2 function in response to DNA damage.14 S.H. Inayat-Hussain et al. / Tox
ny protection in superoxide-mediated oxidation of VDAC and
NT which resulted in mitochondrial release of cytochrome c
Costantini et al., 2000; Madesh and Hajnóczky, 2001). Although
TN induces a loss of Bcl-2 in wild type Jurkat, this may not be cru-
ial as the loss is most probably due to the activation of caspase-3
hich cleaves the anti-apoptotic protein as a relatively late event
n apoptosis (Kirsch et al., 1999). However, the possible involve-
ent of other members of the Bcl-2 family cannot be ruled out.
he precise role of Bcl-2 in the regulation of mitochondria perme-
bilization is still unclear. In this respect, it is tempting to speculate
hat in this study, superoxide-mediated VDAC and/or ANT oxida-
ion may disrupt the binding of Bcl-2 to these proteins. Bcl-2 may
hen be degraded in the cytosol via the proteosomal degradation
ystem.
In conclusion, our data demonstrate that GTN induces ROS and
NA damage in Jurkat cells leading to the activation of an intrinsic
poptotic pathway which is independent of caspase-2 and Bcl-2
egulation.
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